Q2 2024

Filed Aug 14, 2024 · 10-Q · 45 days after period end · 0001096906-24-001703

Q2 2024 · 10-Q

Revenue

$908.39K

+54.4% vs Q2 2023

Net Income

$113.50K

N/M vs Q2 2023

EPS, diluted—

Gross Profit$486,088+70.5%

Operating Cash Flowderived$169,085N/M

Same quarter

Metric	Q2 2024	Q2 2023	Q2 2022	Q2 2021
Revenue	$908.39K	$588.48K	$469.81K	$243.89K
Net Income	$113.50K	-$1.27M	-$859.33K	-$557.75K
EPS Diluted	—	—	—	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Healthy Extracts Inc. · CIK 1630176 · Engraved from SEC EDGAR